Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens

  • 0Sankyo Co, Ltd, Tokyo; Hayashibara Biochemical Laboratories, Inc, Okayama, Japan.

Abstract

Read the full abstract on PubMed

Related Concept Videos